Stool Softener Market Trends, Outlook, Demand, and Insights 2024-2033 | Overview and Forecast

"The new report published by The Business Research Company, titled Stool Softener Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the stool softener market size has grown strongly in recent years. It will grow from $1.58 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The stool softener market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16548&type=smp

Gastrointestinal Disorder Trends Fueling the Expansion Of The Stool Softener Market
The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the stool softener market going forward. Gastrointestinal disorders refer to any condition or disease that affects the gastrointestinal tract, which includes the mouth, esophagus, stomach, small intestine, large intestine, and anus. The increasing prevalence of gastrointestinal disorders is attributed to various factors, including lifestyle changes such as poor diet, lack of exercise, and stress. Stool softeners help alleviate gastrointestinal disorders by making stools easier to pass, thereby preventing constipation and reducing strain during bowel movements. For instance, in 2023, according to Crohn's and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the stool softener market.

Innovations In Opioid-Induced Constipation Medication For Enhanced Patient Relief
Major companies operating in the stool softener market are focusing on product innovations, such as opioid-induced constipation medication, to better serve customers. Opioid-induced constipation (OIC) medication is a type of medication used to treat constipation caused by the use of opioid pain medications. For instance, in February 2021, Endo International plc, a US-based pharmaceutical company, launched Amitiza (Lubiprostone). Amitiza is a prescription medication used to treat chronic idiopathic constipation and irritable bowel syndrome. It works by increasing fluid secretion in the intestines and aiding in bowel movements. Amitiza is approved by the U.S. Food and Drug Administration for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain and for chronic idiopathic (meaning the cause is unknown) constipation.

The stool softener market covered in this report is segmented -

1) By Type: Liquid, Softgel Capsule
2) By Form: Medicines, Procedures
3) By Mode Of Administration: Oral, Rectal
4) By Availability: Over-The-Counter, Prescription
5) By End Use: Hospitals, Clinics, Home Care, Other End Uses

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16548&type=discount

Major companies operating in the stool softener market are F. Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca Plc., Abbott Laboratories Inc., Takeda Pharmaceutical Company Ltd., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Solvay S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Purdue Pharma L.P., Mallinckrodt Plc, Aristo Pharma GmbH, Raptakos Brett Co. Ltd., Unipex Group Inc., Chemo Biological, Angiolife Healthcare Pvt. Ltd., Iscon Life Sciences, Starmed Pvt. Ltd., Phaedrus Ltd., Stadmed Pvt. Ltd., Avrio Health L.P., Healwell, Velnex Medicare, Sanify Healthcare Pvt. Ltd.

Contents of the report:
1. Executive Summary
2. Stool Softener Market Report Structure
3. Stool Softener Market Trends And Strategies
4. Stool Softener Market - Macro Economic Scenario
5. Stool Softener Market Size And Growth
…..
27. Stool Softener Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/stool-softener-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.